| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNISA990005401980203316 |
|
|
Autore |
WILMOTT, Paul |
|
|
Titolo |
Paul Wilmott on quantitative finance / Paul Wilmott |
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Chichester [etc.] John Wiley & Sons, 2000 |
|
|
|
|
|
|
|
Descrizione fisica |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Investimenti -- Modelli matematici |
Opzioni -- Finanza |
Prezzi -- Modelli matematici |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
nuova ed. di: Derivatives, 1998 |
|
|
|
|
|
|
2. |
Record Nr. |
UNINA9910557380403321 |
|
|
Autore |
Caltabiano Rosario |
|
|
Titolo |
Immunohistochemical Expression |
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
|
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (168 p.) |
|
|
|
|
|
|
Soggetti |
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Sommario/riassunto |
|
Immunohistochemistry (IHC) is an ancillary method, widely used in pathologists' practice, that allows identifying diagnostic and |
|
|
|
|
|
|
|
|
|
|
prognostic/predictive of therapeutic response protein markers on tissue samples by the use of specific monoclonal antibodies and chromogenic substances that guarantee the visualization of an antibody-antigene binding complex under a light microscope [1]. Coon et al., in 1941 [2], first introduced the use of fluorochrome-conjugated antibodies in clinical practice. Since then, IHC has gone from being a useful tool for identifying the differentiation line of otherwise undifferentiated cells to a technique capable of providing not only diagnostic but also prognostic and predictive indications of responses to specific therapeutic options [1,3]. The abovementioned peculiarities have made IHC one of the most used ancillary methods in the histopathological approach to human neoplastic and non-neoplastic diseases [3-5]. This Special Issue contains 11 accepted papers that provide readers with a comprehensive update on current and future applications of IHC in medical practice. |
|
|
|
|
|
| |